IL6 and diabetes mellitus: Hyperglycemia (a hallmark of diabetes) has been demonstrated to decrease the basal levels of SOCS3 (an endogenous negative regulator of IL-6-induced STAT signaling), while increasing nuclear phosphorylated-STAT3 in keratinocytes [125].